ClearBridge Investments
VIVO

ClearBridge Investments’s Meridian Bioscience Inc VIVO Stock Holding History

ClearBridge Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,269
Closed -$405K – 851
2021
Q2 		$405K Buy
+18,269
New +$388K ﹤0.01% 781

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

ClearBridge Investments's VIVO Position: Q3 2021 in Review

ClearBridge Investments sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 18,269 shares — an estimated $405K sold.

ClearBridge Investments first reported a position in VIVO in Q2 2021 and held it in 1 quarter. The position peaked at $405K in Q2 2021. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • ClearBridge Investments reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • ClearBridge Investments sold 18,269 Meridian Bioscience Inc shares in Q3 2021, an estimated $405K.
  • ClearBridge Investments first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 1 quarter.
  • ClearBridge Investments's Meridian Bioscience Inc position peaked at $405K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on ClearBridge Investments's 13F filing for Q3 2021, filed 12 Nov 2021.